A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey.
Saved in:
| Title: | A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey. |
|---|---|
| Authors: | Wang XH; Gansu Provincial Cancer Hospital, Lanzhou, China., Wang ZZ; School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China., Xu HF; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China., Liu HW; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China., Wang DL; School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China., Feng CY; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China., Zhang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing, China., Wang WJ; School of Nursing, Jining Medical University, Jining, China., Yu YQ; The Department of Public Health and Preventive Medicine, The Research Center of Clinical epidemiology, Baotou Medical College, Baotou, Inner Mongolia, China., Duan SX; Xinxiang Central Hospital, Xinxiang, China., Shi JH; The Department of Public Health and Preventive Medicine, The Research Center of Clinical epidemiology, Baotou Medical College, Baotou, Inner Mongolia, China., Zhao YQ; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China., Li M; Public Health School, Dalian Medical University, Dalian, China., Liu YY; Liaoning Office for Cancer Control and Research, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China., Huang JX; Wuzhou Red Cross Hospital, Wuzhou, China., Fan YP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Cao J; The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China., Gu XF; Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, China., Li L; Department of Clinical Research, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China., Lian XM; School of Public Health and Management, Chongqing Medical University, Chongqing, China., Du JC; College of Public Health, Chengdu Medical College, Chengdu, China., Qiao YL; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China. |
| Source: | Frontiers in oncology [Front Oncol] 2026 May 14; Vol. 16, pp. 1646284. Date of Electronic Publication: 2026 May 14 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1646284 |
